Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Psoriasis 1Congenital Abnormalities 1Autoimmune Diseases 1Arthritis, Psoriatic 1

Interventions

Flow Cytometry 13Gene Expression Profiling 11Polymerase Chain Reaction 9Psychiatric Rehabilitation 6Microarray Analysis 5DNA Methylation 5Therapeutics 4Immunologic Techniques 4Amplified Fragment Length Polymorphism Analysis 4Reverse Transcriptase Polymerase Chain Reaction 3In Situ Hybridization, Fluorescence 3Immunoenzyme Techniques 3Cytogenetic Analysis 2Blotting, Western 2Base Sequence 2apremilast 1Whole Genome Sequencing 1Watchful Waiting 1Valganciclovir 1Tyrosine Kinase Inhibitors 1Tissue Banks 1Radiography, Panoramic 1Pharmacogenomic Testing 1Peripheral Blood Stem Cell Transplantation 1Patient Reported Outcome Measures 1Mass Spectrometry 1Influenza Vaccines 1Immunosuppression Therapy 1High-Energy Shock Waves 1Health Services Needs and Demand 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Congenital Abnormalities × apremilast × Clear all
NCT02775500 2025-01-28

Apremilast Pregnancy Exposure Registry

University of California, San Diego

Active not recruiting
233 enrolled

Congenital Abnormalities, Autoimmune Diseases, Psoriasis, Arthritis, Psoriatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡